Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy

Abstract Nano‐based immunotherapy of therapeutic biomolecules is attractive but tremendously hampered by the poor delivery efficiency. This study reports a novel delivery system of fluorinated‐coordinative‐epigallocatechin gallate (EGCG), referring as FEGCG/Zn, through the integration of fluorinatio...

Full description

Bibliographic Details
Main Authors: Pengkai Wu, Haitian Zhang, Yin Yin, Meiling Sun, Shuai Mao, Huihui Chen, Yexuan Deng, Shuai Chen, Shuo Li, Beicheng Sun
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202105894
_version_ 1818554722397716480
author Pengkai Wu
Haitian Zhang
Yin Yin
Meiling Sun
Shuai Mao
Huihui Chen
Yexuan Deng
Shuai Chen
Shuo Li
Beicheng Sun
author_facet Pengkai Wu
Haitian Zhang
Yin Yin
Meiling Sun
Shuai Mao
Huihui Chen
Yexuan Deng
Shuai Chen
Shuo Li
Beicheng Sun
author_sort Pengkai Wu
collection DOAJ
description Abstract Nano‐based immunotherapy of therapeutic biomolecules is attractive but tremendously hampered by the poor delivery efficiency. This study reports a novel delivery system of fluorinated‐coordinative‐epigallocatechin gallate (EGCG), referring as FEGCG/Zn, through the integration of fluorination and zinc ions (Zn2+) into EGCG. The robust therapeutics of FEGCG/Zn are measured in terms of the regulating effect on programmed cell death ligand 1 (PD‐L1), the effective delivery of diverse biomolecules, and the hitchhiking ability using living cells. Taking small interfering RNA of PD‐L1 (siPD‐L1) and erythrocytes as an example, the fabricated biomimetic system achieves excellent siPD‐L1 delivery and further improves siPD‐L1 accumulation in tumors. Finally, the combination of FEGCG/Zn and siPD‐L1 promotes antitumor immunotherapy through alleviation of T cells exhaustion by regulating PD‐L1 expression in tumor cells. The results demonstrate that FEGCG/Zn substantially regulates PD‐L1 expression and improves immune‐biomolecule delivery by forming biomimetic nanoassemblies, offering a versatile platform for cancer immunotherapy.
first_indexed 2024-12-12T09:43:49Z
format Article
id doaj.art-e6fce42768d549d88e0f99001ffb0262
institution Directory Open Access Journal
issn 2198-3844
language English
last_indexed 2024-12-12T09:43:49Z
publishDate 2022-05-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj.art-e6fce42768d549d88e0f99001ffb02622022-12-22T00:28:30ZengWileyAdvanced Science2198-38442022-05-01915n/an/a10.1002/advs.202105894Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer TherapyPengkai Wu0Haitian Zhang1Yin Yin2Meiling Sun3Shuai Mao4Huihui Chen5Yexuan Deng6Shuai Chen7Shuo Li8Beicheng Sun9Department of Hepatobiliary Surgery Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing Jiangsu Province 210008 P. R. ChinaDepartment of Hepatobiliary Surgery Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing Jiangsu Province 210008 P. R. ChinaDepartment of Hepatobiliary Surgery Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing Jiangsu Province 210008 P. R. ChinaDepartment of Hepatobiliary Surgery Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing Jiangsu Province 210008 P. R. ChinaDepartment of Hepatobiliary Surgery Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing Jiangsu Province 210008 P. R. ChinaDepartment of Hepatobiliary Surgery Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing Jiangsu Province 210008 P. R. ChinaDepartment of Hepatobiliary Surgery Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School Nanjing Jiangsu Province 210008 P. R. ChinaMOE Key Laboratory of Model Animal for Disease Study Department of Endocrinology Nanjing Drum Tower Hospital and Model Animal Research Center School of Medicine Nanjing University Nanjing 210008 P. R. ChinaDepartment of Gastroenterology The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu Province 210029 P. R. ChinaDepartment of Hepatobiliary Surgery Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University Nanjing Jiangsu Province 210008 P. R. ChinaAbstract Nano‐based immunotherapy of therapeutic biomolecules is attractive but tremendously hampered by the poor delivery efficiency. This study reports a novel delivery system of fluorinated‐coordinative‐epigallocatechin gallate (EGCG), referring as FEGCG/Zn, through the integration of fluorination and zinc ions (Zn2+) into EGCG. The robust therapeutics of FEGCG/Zn are measured in terms of the regulating effect on programmed cell death ligand 1 (PD‐L1), the effective delivery of diverse biomolecules, and the hitchhiking ability using living cells. Taking small interfering RNA of PD‐L1 (siPD‐L1) and erythrocytes as an example, the fabricated biomimetic system achieves excellent siPD‐L1 delivery and further improves siPD‐L1 accumulation in tumors. Finally, the combination of FEGCG/Zn and siPD‐L1 promotes antitumor immunotherapy through alleviation of T cells exhaustion by regulating PD‐L1 expression in tumor cells. The results demonstrate that FEGCG/Zn substantially regulates PD‐L1 expression and improves immune‐biomolecule delivery by forming biomimetic nanoassemblies, offering a versatile platform for cancer immunotherapy.https://doi.org/10.1002/advs.202105894biomimetic deliverycoordinationEGCGfluorineimmunotherapy
spellingShingle Pengkai Wu
Haitian Zhang
Yin Yin
Meiling Sun
Shuai Mao
Huihui Chen
Yexuan Deng
Shuai Chen
Shuo Li
Beicheng Sun
Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy
Advanced Science
biomimetic delivery
coordination
EGCG
fluorine
immunotherapy
title Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy
title_full Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy
title_fullStr Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy
title_full_unstemmed Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy
title_short Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy
title_sort engineered egcg containing biomimetic nanoassemblies as effective delivery platform for enhanced cancer therapy
topic biomimetic delivery
coordination
EGCG
fluorine
immunotherapy
url https://doi.org/10.1002/advs.202105894
work_keys_str_mv AT pengkaiwu engineeredegcgcontainingbiomimeticnanoassembliesaseffectivedeliveryplatformforenhancedcancertherapy
AT haitianzhang engineeredegcgcontainingbiomimeticnanoassembliesaseffectivedeliveryplatformforenhancedcancertherapy
AT yinyin engineeredegcgcontainingbiomimeticnanoassembliesaseffectivedeliveryplatformforenhancedcancertherapy
AT meilingsun engineeredegcgcontainingbiomimeticnanoassembliesaseffectivedeliveryplatformforenhancedcancertherapy
AT shuaimao engineeredegcgcontainingbiomimeticnanoassembliesaseffectivedeliveryplatformforenhancedcancertherapy
AT huihuichen engineeredegcgcontainingbiomimeticnanoassembliesaseffectivedeliveryplatformforenhancedcancertherapy
AT yexuandeng engineeredegcgcontainingbiomimeticnanoassembliesaseffectivedeliveryplatformforenhancedcancertherapy
AT shuaichen engineeredegcgcontainingbiomimeticnanoassembliesaseffectivedeliveryplatformforenhancedcancertherapy
AT shuoli engineeredegcgcontainingbiomimeticnanoassembliesaseffectivedeliveryplatformforenhancedcancertherapy
AT beichengsun engineeredegcgcontainingbiomimeticnanoassembliesaseffectivedeliveryplatformforenhancedcancertherapy